Spotlight Stock,Trends & Articles Tryp Partners With University of Michigan to Test Latest Psychedelics Drug Candidate By Dennis Mutua July 20, 2021 Pharmaceutical company specializing on identifying and developing clinical stage compounds for orphan diseases and mental illnesses Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) announced having entered into a partnership with...
Featured,Trends & Articles Newly Established Chicago Venture Capital Raises $35M to Back Psychedelics Startups By Dennis Mutua July 19, 2021 A recently established venture capital fund in Chicago, Palo Santo announced having raised $35 million which it will be using to back startups which engage in psychedelic and psychedelic-assisted therapies. The venture capital ...
Spotlight Stock,Trends & Articles Dr. Stephen Glazer Appointed as Nova Mentis Director and Chief Science Officer By Dennis Mutua July 16, 2021 Biotechnology company focusing on developing diagnostics and psilocybin based therapeutics for chronic and mental conditions Nova Mentis Life Science Corp. (CSE: NOVA) (OTCQB: NMLSF) announced having appointed Dr. Stephen Glazer a...
Spotlight Stock,Trends & Articles Wesana Health Appoints Ian Burnstein to its Scientific Advisory Board By Dennis Mutua July 15, 2021 Life sciences company focusing on development and delivery of psychedelic therapies to treat traumatic brain injury Wesana Health Corp. (CSE: WESA) announced having appointed Ian Burnstein to its scientific advisory board. Burn...
Featured,Trends & Articles Here Comes World’s First Psychedelic Beverage By Psychedelic Water By Dennis Mutua July 14, 2021 United Sates based psychedelic beverage company Psychedelic Water has unveiled world’s first ever psychedelic beverage which comes as one of its kind in the beverage market. The company says it used Food and Drug Administration ...
Spotlight Stock,Trends & Articles Psilera Bioscience to Receive $2.5 Million From Investors By Dennis Mutua July 13, 2021 Biotechnology company specializing on using psychoactive natural medicines to treat mental illnesses and disorders Psilera Inc. is set to receive $2.5 million from its investors led by a Florida based venture capital firm, Iter In...
Featured,Trends & Articles Liam Payne to Try Magic Mushroom Treatment For Depression By Dennis Mutua July 12, 2021 English singer and songwriter Liam Payne announced that he will be trying magic mushroom as a treatment for depression. Payne will be partnering with Dragon’s Den star Steven Bartlett in the trials of magic mushrooms. Payne w...
Featured,Trends & Articles Atai Founder Cautions on Uncontrolled Legalization of Psychedelics By Dennis Mutua July 09, 2021 Christian Angermayer, the founder of Atai Life Sciences NV (ATAI), a clinical stage biopharmaceutical company specializing on treatment of mental disorders is cautioning that legalization of psychedelics compounds such as magic mu...